Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaafar Bennouna

Showing results (31-40 of 169) with videos related to

Pageof 17
Sort By:
Current Oncology (Toronto, Ont.)|August 26, 2021
Carcinoembryonic Antigen Increase in a Patient with Colon Cancer Who Have Achieved Complete Remission and Negative <sup>18</sup>F-FDG PET/CT: Don't Forget the Thyroid!Alexandre Lugat, Pauline Hulo, Catherine Ansquer, et al.
Frontiers in Oncology|July 12, 2021
Homozygous Co-Deletion of Type I Interferons and <i>CDKN2A</i> Genes in Thoracic Cancers: Potential Consequences for TherapyMarion Grard, Camille Chatelain, Tiphaine Delaunay, et al.
Journal of Immunological Methods|February 28, 2002
Application of IL-5 ELISPOT assays to quantification of antigen-specific T helper responsesJaafar Bennouna, Allan Hildesheim, Kazuaki Chikamatsu, et al.
Clinical Pharmacokinetics|April 5, 2012
Vinflunine oral pharmacokinetics and absolute bioavailability of soft and hard gelatin capsules: results of two phase I trialsJean-Pierre Delord, Jaafar Bennouna, Loïc Mourey, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|November 28, 2020
Investigating the utilization of beam-specific apertures for the intensity-modulated proton therapy (IMPT) head and neck cancer plansSuresh Rana, Mark Storey, Noufal Manthala Padannayil, et al.
Bulletin Du Cancer|March 14, 2024
[National survey of Advanced Practice Nurses in oncology-haematology: Evaluation of activity and continuing education]Elvire Pons-Tostivint, Laure De Decker, Gaëlle Haudebert, et al.
Oncology|October 25, 2017
Bevacizumab in Combination with Platinum-Based Chemotherapy in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with or without Brain Metastases: A French Cohort Study (EOLE)Jaafar Bennouna, Lionel Falchero, Roland Schott, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2020
Efficacy and safety of necitumumab and pembrolizumab combination therapy in patients with Stage IV non-small cell lung cancerBenjamin Besse, Pilar Garrido, Alexis B Cortot, et al.
Current Oncology (Toronto, Ont.)|May 27, 2022
HRAS Q61L Mutation as a Possible Target for Non-Small Cell Lung Cancer: Case Series and Review of LiteratureLaurent Mathiot, Guillaume Herbreteau, Siméon Robin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2017
Safety and Antitumor Activity of the Anti-Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal CarcinomaToshihiko Doi, Sarina A Piha-Paul, Shadia I Jalal, et al.
Pageof 17

Showing results (31-40 of 169) with videos related to

Sort By:
Pageof 17
Current Oncology (Toronto, Ont.)|August 26, 2021
Carcinoembryonic Antigen Increase in a Patient with Colon Cancer Who Have Achieved Complete Remission and Negative <sup>18</sup>F-FDG PET/CT: Don't Forget the Thyroid!Alexandre Lugat, Pauline Hulo, Catherine Ansquer, et al.
Frontiers in Oncology|July 12, 2021
Homozygous Co-Deletion of Type I Interferons and <i>CDKN2A</i> Genes in Thoracic Cancers: Potential Consequences for TherapyMarion Grard, Camille Chatelain, Tiphaine Delaunay, et al.
Journal of Immunological Methods|February 28, 2002
Application of IL-5 ELISPOT assays to quantification of antigen-specific T helper responsesJaafar Bennouna, Allan Hildesheim, Kazuaki Chikamatsu, et al.
Clinical Pharmacokinetics|April 5, 2012
Vinflunine oral pharmacokinetics and absolute bioavailability of soft and hard gelatin capsules: results of two phase I trialsJean-Pierre Delord, Jaafar Bennouna, Loïc Mourey, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|November 28, 2020
Investigating the utilization of beam-specific apertures for the intensity-modulated proton therapy (IMPT) head and neck cancer plansSuresh Rana, Mark Storey, Noufal Manthala Padannayil, et al.
Bulletin Du Cancer|March 14, 2024
[National survey of Advanced Practice Nurses in oncology-haematology: Evaluation of activity and continuing education]Elvire Pons-Tostivint, Laure De Decker, Gaëlle Haudebert, et al.
Oncology|October 25, 2017
Bevacizumab in Combination with Platinum-Based Chemotherapy in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer with or without Brain Metastases: A French Cohort Study (EOLE)Jaafar Bennouna, Lionel Falchero, Roland Schott, et al.
Lung Cancer (Amsterdam, Netherlands)|March 2, 2020
Efficacy and safety of necitumumab and pembrolizumab combination therapy in patients with Stage IV non-small cell lung cancerBenjamin Besse, Pilar Garrido, Alexis B Cortot, et al.
Current Oncology (Toronto, Ont.)|May 27, 2022
HRAS Q61L Mutation as a Possible Target for Non-Small Cell Lung Cancer: Case Series and Review of LiteratureLaurent Mathiot, Guillaume Herbreteau, Siméon Robin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2017
Safety and Antitumor Activity of the Anti-Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal CarcinomaToshihiko Doi, Sarina A Piha-Paul, Shadia I Jalal, et al.
Pageof 17